SCHEMBL10283149

SCHEMBL10283149

CC1(C)c2cc(OCC[C@H](O)CO)ccc2C(=O)c2c1[nH]c1ccc(C#N)cc21

nearest known ligand 0.77

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 20/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29962392 0.87 ALK (1.00) ALK
SCHEMBL897570 0.87 ALK (1.00) ALK
SCHEMBL20004115 0.86 ALK (0.84) ALK
SCHEMBL896663 0.84 ALK (0.87) ALK
SCHEMBL896662 0.84 ALK (0.87) ALK
SCHEMBL896660 0.84 ALK (0.87) ALK
SCHEMBL897148 0.82 ALK (0.82) ALK
SCHEMBL20004117 0.81 ALK (0.81) ALK
SCHEMBL20356879 0.80 ALK (0.87) ALK
SCHEMBL20004492 0.80 ALK (0.87) ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120083488-A1 TETRACYCLIC COMPOUND CHUGAI SEIYAKU KABUSHIKI KAISHA 2012-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120083488-A1 TETRACYCLIC COMPOUND ALK, TTR, ACVR1 ALK 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.